Kaveh S, Mani-Varnosfaderani A, Neiband M
Sci Rep. 2024; 14(1):15315.
PMID: 38961127
PMC: 11222421.
DOI: 10.1038/s41598-024-66173-z.
Liu H, Jian Y, Hou J, Zeng C, Zhao Y
Brief Bioinform. 2023; 25(1).
PMID: 38145947
PMC: 10749790.
DOI: 10.1093/bib/bbad482.
Zhang Q, Chen Y, Teng Z, Lin Z, Liu H
Mol Biol Cell. 2023; 35(2):ar18.
PMID: 38019613
PMC: 10881149.
DOI: 10.1091/mbc.E23-08-0303.
Xiao Y, Dong J
Cells. 2023; 12(16).
PMID: 37626854
PMC: 10453554.
DOI: 10.3390/cells12162044.
Xiao L, Liu Y, Chen H, Shen L
Cancer Biol Ther. 2023; 24(1):2219470.
PMID: 37272701
PMC: 10243401.
DOI: 10.1080/15384047.2023.2219470.
A conditional RNA Pol II mono-promoter drives HIV-inducible, CRISPR-mediated cyclin T1 suppression and HIV inhibition.
Chinnapaiyan S, Santiago M, Panda K, Rahman M, Alluin J, Rossi J
Mol Ther Nucleic Acids. 2023; 32:553-565.
PMID: 37215150
PMC: 10192333.
DOI: 10.1016/j.omtn.2023.04.011.
Novel approaches to targeted protein degradation technologies in drug discovery.
Xue Y, Bolinger A, Zhou J
Expert Opin Drug Discov. 2023; 18(4):467-483.
PMID: 36895136
PMC: 11089573.
DOI: 10.1080/17460441.2023.2187777.
SETD1A regulates transcriptional pause release of heme biosynthesis genes in leukemia.
Hoshii T, Perlee S, Kikuchi S, Rahmutulla B, Fukuyo M, Masuda T
Cell Rep. 2022; 41(9):111727.
PMID: 36450243
PMC: 9771694.
DOI: 10.1016/j.celrep.2022.111727.
CDK2 regulates aminoglycoside-induced hair cell death through modulating c-Jun activity: Inhibiting CDK2 to preserve hearing.
Tao L, Segil N
Front Mol Neurosci. 2022; 15:1013383.
PMID: 36311033
PMC: 9606710.
DOI: 10.3389/fnmol.2022.1013383.
hnRNP R negatively regulates transcription by modulating the association of P-TEFb with 7SK and BRD4.
Ji C, Deng C, Antor K, Bischler T, Schneider C, Fischer U
EMBO Rep. 2022; 23(9):e55432.
PMID: 35856391
PMC: 9442301.
DOI: 10.15252/embr.202255432.
A curious case of cyclin-dependent kinases in neutrophils.
Syahirah R, Hsu A, Deng Q
J Leukoc Biol. 2022; 111(5):1057-1068.
PMID: 35188696
PMC: 9035055.
DOI: 10.1002/JLB.2RU1021-573R.
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Anshabo A, Milne R, Wang S, Albrecht H
Front Oncol. 2021; 11:678559.
PMID: 34041038
PMC: 8143439.
DOI: 10.3389/fonc.2021.678559.
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Lukasik P, Zaluski M, Gutowska I
Int J Mol Sci. 2021; 22(6).
PMID: 33805800
PMC: 7998717.
DOI: 10.3390/ijms22062935.
The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.
McAnulty J, DiFeo A
Int J Mol Sci. 2020; 21(24).
PMID: 33322239
PMC: 7764474.
DOI: 10.3390/ijms21249486.
Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
Yao G, Tang J, Yang X, Zhao Y, Zhou R, Meng R
Theranostics. 2020; 10(24):11144-11158.
PMID: 33042275
PMC: 7532664.
DOI: 10.7150/thno.42578.
Cyclin-dependent kinases and rare developmental disorders.
Colas P
Orphanet J Rare Dis. 2020; 15(1):203.
PMID: 32762766
PMC: 7410148.
DOI: 10.1186/s13023-020-01472-y.
Nutraceutical Compounds as Sensitizers for Cancer Treatment in Radiation Therapy.
Calvaruso M, Pucci G, Musso R, Bravata V, Cammarata F, Russo G
Int J Mol Sci. 2019; 20(21).
PMID: 31652849
PMC: 6861933.
DOI: 10.3390/ijms20215267.
Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.
Cartwright J, Lucas C, Rossi A
Front Pharmacol. 2019; 10:55.
PMID: 30886578
PMC: 6389705.
DOI: 10.3389/fphar.2019.00055.
Cyclin C: The Story of a Non-Cycling Cyclin.
Jezek J, Smethurst D, Stieg D, Kiss Z, Hanley S, Ganesan V
Biology (Basel). 2019; 8(1).
PMID: 30621145
PMC: 6466611.
DOI: 10.3390/biology8010003.
The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
Garcia-Reyes B, Kretz A, Ruff J, von Karstedt S, Hillenbrand A, Knippschild U
Int J Mol Sci. 2018; 19(10).
PMID: 30340359
PMC: 6214075.
DOI: 10.3390/ijms19103219.